Neoadjuvant therapy versus upfront surgery approach in resectable pancreatic cancer: a systematic review and meta-analysis.

Ann Gastroenterol · 2025 · PMC12277514 · PMID 40697437

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Current standard chemotherapy regimens showed a trend towards greater DFS compared to upfront surgery, although it was not significant (HR 1.30, 95%CI 0.97-1.76; P=0.08).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.